These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
182 related items for PubMed ID: 7279699
1. Serial carcinoembryonic antigen (CEA) determinations in the management of metastatic breast cancer. Lamerz R, Leonhardt A, Ehrhart H, von Lieven H. Oncodev Biol Med; 1980; 1(2):123-35. PubMed ID: 7279699 [Abstract] [Full Text] [Related]
2. Serial carcinoembryonic antigen (CEA) determinations in the management of patients with breast cancer. Staab HJ, Ahlemann LM, Koch HL, Anderer FA. Oncodev Biol Med; 1980; 1(3):151-60. PubMed ID: 7279702 [Abstract] [Full Text] [Related]
3. Serial CEA determinations as an aid in postoperative therapy management of patients with early breast cancer. Ahlemann LM, Staab HJ, Anderer FA. Biomedicine; 1980 Dec; 32(4):194-9. PubMed ID: 7470582 [Abstract] [Full Text] [Related]
4. [Clinical significance of elevated CEA values in the follow-up management of patients with breast cancer]. Paulick R, Caffier H. Geburtshilfe Frauenheilkd; 1985 Nov; 45(11):774-9. PubMed ID: 4076751 [Abstract] [Full Text] [Related]
5. [Carcinoembryonic antigens (CEA) in patients with metastatic breast cancer under endocrine and therapeutic treatment (author's transl)]. Pompecki R, Schröder G, Garbrecht M, Frahm H. Dtsch Med Wochenschr; 1978 Apr 07; 103(14):620-2. PubMed ID: 639696 [Abstract] [Full Text] [Related]
7. Human tissue polypeptide antigen in breast cancer. Nemoto T, Constantine R, Chu TM. J Natl Cancer Inst; 1979 Dec 07; 63(6):1347-50. PubMed ID: 292806 [Abstract] [Full Text] [Related]
8. Role of plasma carcinoembryonic antigen in evaluating patients with breast cancer treated with adjuvant chemotherapy. Falkson HC, van der Watt JJ, Portugal MA, Schoeman HS, Falkson G. Cancer Treat Rep; 1979 Aug 07; 63(8):1303-9. PubMed ID: 476707 [Abstract] [Full Text] [Related]
9. Carcinoembryonic antigen: an invaluable marker for advanced breast cancer. Pathak KA, Khanna R, Khanna HD, Khanna S, Gupta S, Khanna NN. J Postgrad Med; 1996 Aug 07; 42(3):68-71. PubMed ID: 9715319 [Abstract] [Full Text] [Related]
10. Comparison of CA15-3 and carcinoembryonic antigen in monitoring the clinical course of patients with metastatic breast cancer. Tondini C, Hayes DF, Gelman R, Henderson IC, Kufe DW. Cancer Res; 1988 Jul 15; 48(14):4107-12. PubMed ID: 3164256 [Abstract] [Full Text] [Related]
11. Elevated serum carcinoembryonic antigen and prognosis of breast cancer patients postmastectomy. Paulick R, Caffier H. Cancer Detect Prev; 1988 Jul 15; 11(3-6):311-7. PubMed ID: 3390852 [Abstract] [Full Text] [Related]
14. Carcinoembryonic-like substance in breast fluid discharge in benign and malignant breast disease and in milk of lactating women. Kahana L, Bartal AH, Yechieli H, Guttman I, Sheinfeld M. Isr J Med Sci; 1981 Nov 15; 17(11):1035-40. PubMed ID: 7319791 [Abstract] [Full Text] [Related]
15. Carcinoembryonic antigen in tissue and serum from breast cancer patients relationship with steroid receptors and clinical applications in the prognosis and early diagnosis of relapse. Molina R, Farrus B, Filella X, Jo J, Zanón G, Pahisa J, Latre M, Muñoz M, Ballesta AM. Anticancer Res; 1999 Nov 15; 19(4A):2557-62. PubMed ID: 10470194 [Abstract] [Full Text] [Related]
18. Clinical value of TPS, CEA and CA 15-3 in breast cancer patients. Blijlevens NM, Oosterhuis WP, Oosten HR, Mulder NH. Anticancer Res; 1995 Nov 15; 15(6B):2711-6. PubMed ID: 8669851 [Abstract] [Full Text] [Related]